Skip to main content
HR 2026 115th Congress House Health Drug safety, medical device, and laboratory regulation Fraud offenses and financial crimes Health information and medical records Medical research

Pharmaceutical Information Exchange Act

Introduced: April 6, 2017 Introduced by: Guthrie, Brett Republican · Kentucky See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 17, 2018
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
Jan 17, 2018
Subcommittee Consideration and Mark-up Session Held.
Apr 7, 2017
Referred to the Subcommittee on Health.
Apr 6, 2017
Referred to the House Committee on Energy and Commerce.
Apr 6, 2017
Introduced in House
 Plain-English summary Congressional Research Service

Pharmaceutical Information Exchange Act

This bill amends the Federal Food, Drug, and Cosmetic Act to allow information about a new investigational medication or the investigational use of a medication approved by the Food and Drug Administration to be provided to health care entities if the information is based on reliable scientific evidence.

What's happening now January 17, 2018

Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .

 Committees of jurisdiction 2